D89.810

Clinical Causes: Receiving a stem cell or bone marrow transplant from a donor Mismatch or incompatibility between donor and recipient immune systems Presence of immunosuppressive therapy that affects immune response Certain underlying medical conditions that predispose to immune activation

Key Symptoms: Skin rash, often starting on the palms or soles and spreading Swelling, redness, and pain in the affected skin areas Liver involvement leading to jaundice (yellowing of the skin and eyes) Gastrointestinal issues such as nausea, vomiting, diarrhea, and abdominal pain Fever and malaise (general feeling of discomfort or illness) Elevated liver enzymes detected via blood tests

Diagnosis Path: Diagnosis of acute GVHD is based on a combination of clinical examination, medical history, and laboratory tests. Key procedures may include: - Physical evaluation focusing on skin, liver, and gastrointestinal symptoms - Blood tests to assess liver function and immune activity - Biopsies of skin or affected organs to confirm tissue damage - Imaging studies if necessary to evaluate internal organs A thorough assessment helps differentiate GVHD from other conditions with similar symptoms, ensuring accurate diagnosis.

Treatment Protocols: Managing acute GVHD involves a combination of therapies aimed at controlling immune response and alleviating symptoms. Typical approaches include: - Immunosuppressive medications such as corticosteroids, calcineurin inhibitors, or methotrexate - Supportive care to address symptoms like skin rashes, gastrointestinal discomfort, and liver issues - Infection prevention and treatment due to increased vulnerability during immunosuppression - Regular monitoring to assess disease progression and response to therapy - In some cases, experimental treatments or clinical trials may be considered for refractory cases Early detection and intervention are key to improving outcomes and minimizing organ damage caused by the condition.